A randomized controlled trial of intravenous magnesium sulphate as an adjunct to standard therapy in atrial fibrillation

Data publikacji: 23 sie 2022

Zakres stron: 91 - 101

Otrzymano: 14 kwi 2022

Przyjęty: 04 cze 2022

DOI: https://doi.org/10.2478/acm-2022-0011

Słowa kluczowe

Atrial fibrillation, Magnesium sulphate, heart rate, sinus rhythm

© 2022 Raghu K. et al., published by Sciendo

This work is licensed under the Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License.